A team of scientists has obtained the first detailed look at how a molecular Ferris wheel delivers protons to cellular factories, providing new insights into how cells generate energy.
The research, published in the journal Nature, focuses on a protein complex called the ATP synthase, which is found in the inner membranes of mitochondria, the powerhouses of cells. ATP synthase uses the energy from a proton gradient to generate adenosine triphosphate (ATP), the cell's main energy currency.
The ATP synthase complex is made up of two rotating subunits, called the F1 and F0 subunits. The F1 subunit contains the catalytic site where ATP is synthesized, while the F0 subunit is responsible for generating the proton gradient.
The new study, led by scientists at the University of California, Berkeley, reveals how the F0 subunit of ATP synthase uses a series of proton-binding sites to transport protons across the membrane. The protons are bound to the sites in a specific order, and as the F0 subunit rotates, the protons are passed from one site to the next until they reach the catalytic site in the F1 subunit.
This process is similar to the way that a Ferris wheel transports people from one place to another. The protons are bound to the proton-binding sites like people are bound to the seats of a Ferris wheel. As the Ferris wheel rotates, the people are transported to the top of the wheel, where they can disembark.
In the case of ATP synthase, the protons are transported to the catalytic site, where they are used to generate ATP. This process is essential for the cell's survival, as ATP is required for a variety of cellular functions, including cell growth, movement, and metabolism.
The new study provides a detailed understanding of how ATP synthase works, and it could lead to the development of new drugs that target this complex. Such drugs could be used to treat a variety of diseases, including cancer and heart disease.
"This research is a major breakthrough in our understanding of how cells generate energy," said study senior author Dr. John Walker, a professor of molecular biology at the University of California, Berkeley. "The insights gained from this study could lead to the development of new treatments for a variety of diseases."
